Workshop To Address Public Interest And CRISPR Gene Editing, CAR T Cancer Treatment 04/09/2017 by Intellectual Property Watch Leave a Comment Experts at a one-day workshop in Washington DC next week will discuss public interest aspects of patents and two breakthrough new medical technologies related to gene editing (CRISPR) and cancer treatment (CAR T).
Key IP Delegates In Geneva – Fully Updated! 01/09/2017 by William New, Intellectual Property Watch Leave a Comment Geneva, Switzerland is the gathering point for the world’s governments to set international policy and practices relating to intellectual property rights, as they cut across many of the public policy issues of the day (eg innovation, trade, internet, health, food), including at the World Intellectual Property Organization, World Trade Organization and World Health Organization. Everyone has a stake in what governments and their stakeholders do in these venues. But who do you talk to in order to get your message through? Now Intellectual Property Watch has fully updated its unique list of the diplomats representing many of the key nations in those institutions in Geneva. Available here for subscribers only!
Between Human Rights And IP: An Interview With Laurence Helfer, Co-Author Of Guide To Marrakesh Treaty Implementation 31/08/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment When in 2013, in Marrakesh, Morocco, a new World Intellectual Property Organization treaty establishing exceptions and limitations for people with visual impairment was adopted, it was hailed by some as a miracle. Entered into force in 2016, the way states implement the treaty is of major importance for the World Blind Union (WBU) so that the treaty serves its purpose to expand access to books for visually impaired people. Laurence Helfer is co-author of a Guide: The World Blind Union Guide to the Marrakesh Treaty: Facilitating Access to Books for Print-Disabled Individuals. Alongside the recent session of the United Nations Committee on the Rights of Persons with Disabilities, he sat down with Intellectual Property Watch Senior Writer Catherine Saez to explain the main aims and messages of the Guide.
Industry Study Looks At Economics Of Trademark-Intensive Industries In SE Asia 30/08/2017 by Intellectual Property Watch Leave a Comment A trademark industry study released today looks at the economic contribution of trademark-intensive industries in five countries in the Southeast Asian region, and finds they are making a significant contribution. The study puts a particular focus on Singapore.
Law Enforcement, Industry Hold Event Against IP Crime At UN 29/08/2017 by William New, Intellectual Property Watch Leave a Comment NEW YORK – An event of international law enforcement, security experts and industry this week at the United Nations headquarters in New York aimed at building strategies against a wide range of intellectual property crime worldwide. At the event, a senior United States official discussed plans to expand a program of US IP experts abroad.
US Lobby Group Fights China’s Inclusion Of Generic Food Names In EU GI Deal 28/08/2017 by William New, Intellectual Property Watch Leave a Comment China and the European Union appear to be on track to complete a deal on geographical indications that could include protection of some 100 products each from the EU and China. Comments have been received on the proposed list and are undergoing translation. Among them, a United States lobby group said the list for China to protect unfairly includes several generic food names that should not belong solely to the EU.
Did Monsanto Write Malawi’s Seed Policy? 25/08/2017 by Intellectual Property Watch 1 Comment Tim Wise writes: In late July, a short article was published in a Malawian newspaper: “Press Release on Organization of Seed Fairs.” Issued by the Ministry of Agriculture, Irrigation, and Water Development, in conjunction with the Seed Traders Association of Malawi, the short statement advised the public that “only quality certified seed suppliers registered with Government to produce and/or market seed should be allowed to display seed at such events.” The release was signed by Bright Kumwembe for the Agriculture Ministry. I received this news in the United States as I prepared a research trip to Malawi, and I was shocked. Malawi is in the final stages of a multi-year effort to reform its seed policy and laws, and the largest point of contention at this point is the failure of the draft policy to recognize and protect so-called “farmers’ rights” to save, exchange, and sell the seeds they grow on their farms.
WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy 24/08/2017 by William New, Intellectual Property Watch 1 Comment A United States State Department science envoy quit yesterday in protest over US President Donald Trump’s pullout from the Paris climate accord and defensive comments after violence at a white nationalist rally in Charlottesville, Virginia. But according to a press report, Peter Hotez, a past science adviser who has been a featured speaker of a UN agency and pharmaceutical industry group in Geneva, is stepping up to offer his services without concern for Trump’s actions.
US Issues Spate Of Trade Announcements, With IP In The Foreground 22/08/2017 by William New, Intellectual Property Watch Leave a Comment With much of the rest of the western world on holidays, the Office of the United States Trade Representative spent this month in meetings and issuing statements about improving international trade conditions for the US. Over the past two weeks, United States Trade Representative Robert Lighthizer and other senior officials have been involved in activities with Canada and Mexico (under renegotiation of the 1994 North American Free Trade Agreement, NAFTA), Japan, South Korea, and China.
Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 by William New, Intellectual Property Watch Leave a Comment A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases.